GXP RIZATRIPTAN rizatriptan (as benzoate) 10 mg orally disintegrating tablets blisters

Šalis: Australija

kalba: anglų

Šaltinis: Department of Health (Therapeutic Goods Administration)

Veiklioji medžiaga:

rizatriptan benzoate, Quantity: 14.53 mg (Equivalent: rizatriptan, Qty 10 mg)

Prieinama:

Arrotex Pharmaceuticals Pty Ltd

INN (Tarptautinis Pavadinimas):

rizatriptan benzoate

Vaisto forma:

Tablet, orally disintegrating

Sudėtis:

Excipient Ingredients: acesulfame potassium; crospovidone; ethylcellulose; hypromellose; sodium stearylfumarate; silicon dioxide; mannitol; colloidal anhydrous silica; Flavour

Vartojimo būdas:

Sublingual

Vienetai pakuotėje:

3, 1, 6, 2

Recepto tipas:

(S4) Prescription Only Medicine

Terapinės indikacijos:

for acute treatment of migraine attacks with or without aura.

Produkto santrauka:

Visual Identification: White to off-white, round, flat face beveled edge tablets, debossed with 'C7' on one side and 'C' on the other side, having a characteristic flavour.; Container Type: Blister Pack; Container Material: Other composite material; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Autorizacija statusas:

Licence status A

Leidimo data:

2015-03-20